List of Tables
Table 1. Global Biologic Peptide API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Biologic Peptide API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Biologic Peptide API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Biologic Peptide API Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biologic Peptide API Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Biologic Peptide API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
Table 7. Global Biologic Peptide API Sales by Region (2020-2025) & (Kilotons)
Table 8. Global Biologic Peptide API Sales by Region (2026-2031) & (Kilotons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Biologic Peptide API Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
Table 11. Global Biologic Peptide API Production by Region (2020-2025) & (Kilotons)
Table 12. Global Biologic Peptide API Production by Region (2026-2031) & (Kilotons)
Table 13. Global Biologic Peptide API Sales by Manufacturers (2020-2025) & (Kilotons)
Table 14. Global Biologic Peptide API Sales Share by Manufacturers (2020-2025)
Table 15. Global Biologic Peptide API Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Biologic Peptide API Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Biologic Peptide API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Peptide API as of 2024)
Table 19. Global Biologic Peptide API Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Biologic Peptide API Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Biologic Peptide API Manufacturing Base and Headquarters
Table 22. Global Biologic Peptide API Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Biologic Peptide API Sales by Type (2020-2025) & (Kilotons)
Table 26. Global Biologic Peptide API Sales by Type (2026-2031) & (Kilotons)
Table 27. Global Biologic Peptide API Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Biologic Peptide API Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Biologic Peptide API ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Biologic Peptide API Sales by Application (2020-2025) & (Kilotons)
Table 32. Global Biologic Peptide API Sales by Application (2026-2031) & (Kilotons)
Table 33. Biologic Peptide API High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Biologic Peptide API Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Biologic Peptide API Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Biologic Peptide API ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Biologic Peptide API Growth Accelerators and Market Barriers
Table 40. North America Biologic Peptide API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Biologic Peptide API Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Biologic Peptide API Growth Accelerators and Market Barriers
Table 43. Europe Biologic Peptide API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Biologic Peptide API Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Biologic Peptide API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Biologic Peptide API Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Biologic Peptide API Growth Accelerators and Market Barriers
Table 48. Southeast Asia Biologic Peptide API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Biologic Peptide API Investment Opportunities and Key Challenges
Table 50. Central and South America Biologic Peptide API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Biologic Peptide API Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Biologic Peptide API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Bachem Corporation Information
Table 54. Bachem Description and Major Businesses
Table 55. Bachem Product Models, Descriptions and Specifications
Table 56. Bachem Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Bachem Sales Value Proportion by Product in 2024
Table 58. Bachem Sales Value Proportion by Application in 2024
Table 59. Bachem Sales Value Proportion by Geographic Area in 2024
Table 60. Bachem Biologic Peptide API SWOT Analysis
Table 61. Bachem Recent Developments
Table 62. GenScript Corporation Information
Table 63. GenScript Description and Major Businesses
Table 64. GenScript Product Models, Descriptions and Specifications
Table 65. GenScript Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. GenScript Sales Value Proportion by Product in 2024
Table 67. GenScript Sales Value Proportion by Application in 2024
Table 68. GenScript Sales Value Proportion by Geographic Area in 2024
Table 69. GenScript Biologic Peptide API SWOT Analysis
Table 70. GenScript Recent Developments
Table 71. AmbioPharm Corporation Information
Table 72. AmbioPharm Description and Major Businesses
Table 73. AmbioPharm Product Models, Descriptions and Specifications
Table 74. AmbioPharm Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. AmbioPharm Sales Value Proportion by Product in 2024
Table 76. AmbioPharm Sales Value Proportion by Application in 2024
Table 77. AmbioPharm Sales Value Proportion by Geographic Area in 2024
Table 78. AmbioPharm Biologic Peptide API SWOT Analysis
Table 79. AmbioPharm Recent Developments
Table 80. Limitless Biotech Corporation Information
Table 81. Limitless Biotech Description and Major Businesses
Table 82. Limitless Biotech Product Models, Descriptions and Specifications
Table 83. Limitless Biotech Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Limitless Biotech Sales Value Proportion by Product in 2024
Table 85. Limitless Biotech Sales Value Proportion by Application in 2024
Table 86. Limitless Biotech Sales Value Proportion by Geographic Area in 2024
Table 87. Limitless Biotech Biologic Peptide API SWOT Analysis
Table 88. Limitless Biotech Recent Developments
Table 89. CPC Scientific Corporation Information
Table 90. CPC Scientific Description and Major Businesses
Table 91. CPC Scientific Product Models, Descriptions and Specifications
Table 92. CPC Scientific Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. CPC Scientific Sales Value Proportion by Product in 2024
Table 94. CPC Scientific Sales Value Proportion by Application in 2024
Table 95. CPC Scientific Sales Value Proportion by Geographic Area in 2024
Table 96. CPC Scientific Biologic Peptide API SWOT Analysis
Table 97. CPC Scientific Recent Developments
Table 98. PolyPeptide Corporation Information
Table 99. PolyPeptide Description and Major Businesses
Table 100. PolyPeptide Product Models, Descriptions and Specifications
Table 101. PolyPeptide Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. PolyPeptide Recent Developments
Table 103. CordenPharma Corporation Information
Table 104. CordenPharma Description and Major Businesses
Table 105. CordenPharma Product Models, Descriptions and Specifications
Table 106. CordenPharma Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. CordenPharma Recent Developments
Table 108. Lonza Corporation Information
Table 109. Lonza Description and Major Businesses
Table 110. Lonza Product Models, Descriptions and Specifications
Table 111. Lonza Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Lonza Recent Developments
Table 113. Aspen API Corporation Information
Table 114. Aspen API Description and Major Businesses
Table 115. Aspen API Product Models, Descriptions and Specifications
Table 116. Aspen API Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Aspen API Recent Developments
Table 118. Syngene Corporation Information
Table 119. Syngene Description and Major Businesses
Table 120. Syngene Product Models, Descriptions and Specifications
Table 121. Syngene Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Syngene Recent Developments
Table 123. USV Peptides Corporation Information
Table 124. USV Peptides Description and Major Businesses
Table 125. USV Peptides Product Models, Descriptions and Specifications
Table 126. USV Peptides Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. USV Peptides Recent Developments
Table 128. Bio Basic Corporation Information
Table 129. Bio Basic Description and Major Businesses
Table 130. Bio Basic Product Models, Descriptions and Specifications
Table 131. Bio Basic Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 132. Bio Basic Recent Developments
Table 133. JPT Peptide Technologies Corporation Information
Table 134. JPT Peptide Technologies Description and Major Businesses
Table 135. JPT Peptide Technologies Product Models, Descriptions and Specifications
Table 136. JPT Peptide Technologies Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 137. JPT Peptide Technologies Recent Developments
Table 138. ScinoPharm Corporation Information
Table 139. ScinoPharm Description and Major Businesses
Table 140. ScinoPharm Product Models, Descriptions and Specifications
Table 141. ScinoPharm Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 142. ScinoPharm Recent Developments
Table 143. Piramal Pharma Corporation Information
Table 144. Piramal Pharma Description and Major Businesses
Table 145. Piramal Pharma Product Models, Descriptions and Specifications
Table 146. Piramal Pharma Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 147. Piramal Pharma Recent Developments
Table 148. Jiangsu Sinopep-Allsino Biopharmaceutical Corporation Information
Table 149. Jiangsu Sinopep-Allsino Biopharmaceutical Description and Major Businesses
Table 150. Jiangsu Sinopep-Allsino Biopharmaceutical Product Models, Descriptions and Specifications
Table 151. Jiangsu Sinopep-Allsino Biopharmaceutical Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 152. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments
Table 153. Cheng Du Sheng Nuo Biotec Corporation Information
Table 154. Cheng Du Sheng Nuo Biotec Description and Major Businesses
Table 155. Cheng Du Sheng Nuo Biotec Product Models, Descriptions and Specifications
Table 156. Cheng Du Sheng Nuo Biotec Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 157. Cheng Du Sheng Nuo Biotec Recent Developments
Table 158. Hybio Pharmaceutical Corporation Information
Table 159. Hybio Pharmaceutical Description and Major Businesses
Table 160. Hybio Pharmaceutical Product Models, Descriptions and Specifications
Table 161. Hybio Pharmaceutical Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 162. Hybio Pharmaceutical Recent Developments
Table 163. Hainan Shuangcheng Pharmaceuticals Corporation Information
Table 164. Hainan Shuangcheng Pharmaceuticals Description and Major Businesses
Table 165. Hainan Shuangcheng Pharmaceuticals Product Models, Descriptions and Specifications
Table 166. Hainan Shuangcheng Pharmaceuticals Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 167. Hainan Shuangcheng Pharmaceuticals Recent Developments
Table 168. Guangdong Jianyuan Pharmaceutical Corporation Information
Table 169. Guangdong Jianyuan Pharmaceutical Description and Major Businesses
Table 170. Guangdong Jianyuan Pharmaceutical Product Models, Descriptions and Specifications
Table 171. Guangdong Jianyuan Pharmaceutical Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 172. Guangdong Jianyuan Pharmaceutical Recent Developments
Table 173. Zhejiang Peptites Biotech Corporation Information
Table 174. Zhejiang Peptites Biotech Description and Major Businesses
Table 175. Zhejiang Peptites Biotech Product Models, Descriptions and Specifications
Table 176. Zhejiang Peptites Biotech Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 177. Zhejiang Peptites Biotech Recent Developments
Table 178. Key Raw Materials Distribution
Table 179. Raw Materials Key Suppliers
Table 180. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 181. Milestones in Production Technology Evolution
Table 182. Distributors List
Table 183. Market Trends and Market Evolution
Table 184. Market Drivers and Opportunities
Table 185. Market Challenges, Risks, and Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Peptide API Product Picture
Figure 2. Global Biologic Peptide API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Bioactive Peptides Product Picture
Figure 4. Synthetic Peptides Product Picture
Figure 5. Global Biologic Peptide API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Pharmaceuticals
Figure 7. Scientific Research
Figure 8. Other
Figure 9. Biologic Peptide API Report Years Considered
Figure 10. Global Biologic Peptide API Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 12. Global Biologic Peptide API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Biologic Peptide API Revenue Market Share by Region (2020-2031)
Figure 14. Global Biologic Peptide API Sales (2020-2031) & (Kilotons)
Figure 15. Global Biologic Peptide API Sales (CAGR) by Region (2020-2031) (Kilotons)
Figure 16. Global Biologic Peptide API Sales Market Share by Region (2020-2031)
Figure 17. Global Biologic Peptide API Capacity, Production and Utilization (2020-2031) & (Kilotons)
Figure 18. Global Biologic Peptide API Production Trend by Region (2020-2031) (Kilotons)
Figure 19. Global Biologic Peptide API Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Biologic Peptide API Production Growth Rate in North America (2020-2031) & (Kilotons)
Figure 22. Biologic Peptide API Production Growth Rate in Europe (2020-2031) & (Kilotons)
Figure 23. Biologic Peptide API Production Growth Rate in China (2020-2031) & (Kilotons)
Figure 24. Biologic Peptide API Production Growth Rate in Japan (2020-2031) & (Kilotons)
Figure 25. Top 5 and Top 10 Manufacturers Biologic Peptide API Sales Volume Market Share in 2024
Figure 26. Global Biologic Peptide API Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Bioactive Peptides Revenue Market Share by Manufacturer in 2024
Figure 29. Synthetic Peptides Revenue Market Share by Manufacturer in 2024
Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 32. Global Biologic Peptide API Sales Market Share by Type (2020-2031)
Figure 33. Global Biologic Peptide API Revenue Market Share by Type (2020-2031)
Figure 34. Global Biologic Peptide API Sales Market Share by Application (2020-2031)
Figure 35. Global Biologic Peptide API Revenue Market Share by Application (2020-2031)
Figure 36. North America Biologic Peptide API Sales YoY (2020-2031) & (Kilotons)
Figure 37. North America Biologic Peptide API Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Biologic Peptide API Sales Revenue (US$ Million) in 2024
Figure 39. North America Biologic Peptide API Sales Volume (Kilotons) by Type (2020- 2031)
Figure 40. North America Biologic Peptide API Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Biologic Peptide API Sales Volume (Kilotons) by Application (2020-2031)
Figure 42. North America Biologic Peptide API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Biologic Peptide API Sales YoY (2020-2031) & (Kilotons)
Figure 47. Europe Biologic Peptide API Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Biologic Peptide API Sales Revenue (US$ Million) in 2024
Figure 49. Europe Biologic Peptide API Sales Volume (Kilotons) by Type (2020-2031)
Figure 50. Europe Biologic Peptide API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Biologic Peptide API Sales Volume (Kilotons) by Application (2020-2031)
Figure 52. Europe Biologic Peptide API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 54. France Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Biologic Peptide API Sales YoY (2020-2031) & (Kilotons)
Figure 59. Asia-Pacific Biologic Peptide API Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Biologic Peptide API Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Biologic Peptide API Sales Volume (Kilotons) by Type (2020- 2031)
Figure 62. Asia-Pacific Biologic Peptide API Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Biologic Peptide API Sales Volume (Kilotons) by Application (2020-2031)
Figure 64. Asia-Pacific Biologic Peptide API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 69. India Biologic Peptide API Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Biologic Peptide API Sales YoY (2020-2031) & (Kilotons)
Figure 71. Central and South America Biologic Peptide API Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Biologic Peptide API Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Biologic Peptide API Sales Volume (Kilotons) by Type (2021-2031)
Figure 74. Central and South America Biologic Peptide API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Biologic Peptide API Sales Volume (Kilotons) by Application (2020-2031)
Figure 76. Central and South America Biologic Peptide API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Biologic Peptide API Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Biologic Peptide API Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Biologic Peptide API Sales YoY (2020-2031) & (Kilotons)
Figure 80. Middle East and Africa Biologic Peptide API Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Biologic Peptide API Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Biologic Peptide API Sales Volume (Kilotons) by Type (2021-2031)
Figure 83. South America Biologic Peptide API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Biologic Peptide API Sales Volume (Kilotons) by Application (2020-2031)
Figure 85. Middle East and Africa Biologic Peptide API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Biologic Peptide API Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Biologic Peptide API Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Biologic Peptide API Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Biologic Peptide API Revenue (2020-2025) & (US$ Million)
Figure 90. Biologic Peptide API Industry Chain Mapping
Figure 91. Regional Biologic Peptide API Manufacturing Base Distribution (%)
Figure 92. Biologic Peptide API Production Process
Figure 93. Regional Biologic Peptide API Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
